Deqin Wu

407 total citations
10 papers, 287 citations indexed

About

Deqin Wu is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Deqin Wu has authored 10 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pharmacology. Recurrent topics in Deqin Wu's work include RNA modifications and cancer (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Deqin Wu is often cited by papers focused on RNA modifications and cancer (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Deqin Wu collaborates with scholars based in China. Deqin Wu's co-authors include Wen Gao, Yongqian Shu, Tao Yu, Pei Ma, Jing He, Shidai Jin, Jun Li, Yufeng Gu, Wentao Liu and Yimei Cai and has published in prestigious journals such as Drugs, Journal of Neuroinflammation and Biomedicine & Pharmacotherapy.

In The Last Decade

Deqin Wu

10 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deqin Wu China 8 164 125 39 28 27 10 287
Lan Song China 11 190 1.2× 122 1.0× 39 1.0× 12 0.4× 19 0.7× 26 341
Yihao Wang China 10 173 1.1× 71 0.6× 28 0.7× 13 0.5× 40 1.5× 27 329
Xue Zhao China 12 142 0.9× 77 0.6× 23 0.6× 17 0.6× 14 0.5× 34 342
Abdul Aziz Mohamed Yusoff Malaysia 12 260 1.6× 87 0.7× 33 0.8× 8 0.3× 23 0.9× 39 418
Chengfei Xu China 11 158 1.0× 114 0.9× 33 0.8× 13 0.5× 58 2.1× 25 288
Shengtao Liao China 10 219 1.3× 136 1.1× 20 0.5× 9 0.3× 17 0.6× 27 366
David Arias Ron Spain 6 136 0.8× 71 0.6× 39 1.0× 14 0.5× 14 0.5× 10 283
Shuai Guo China 9 169 1.0× 51 0.4× 23 0.6× 8 0.3× 29 1.1× 17 294
Ying Feng China 10 189 1.2× 88 0.7× 19 0.5× 12 0.4× 10 0.4× 20 291

Countries citing papers authored by Deqin Wu

Since Specialization
Citations

This map shows the geographic impact of Deqin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deqin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deqin Wu more than expected).

Fields of papers citing papers by Deqin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deqin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deqin Wu. The network helps show where Deqin Wu may publish in the future.

Co-authorship network of co-authors of Deqin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Deqin Wu. A scholar is included among the top collaborators of Deqin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deqin Wu. Deqin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wu, Deqin, Jing He, Kai Wang, et al.. (2020). CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression. Aging. 12(11). 10578–10593. 23 indexed citations
2.
Jin, Shidai, Jing He, Yue Zhou, et al.. (2020). LncRNA FTX activates FOXA2 expression to inhibit non–small‐cell lung cancer proliferation and metastasis. Journal of Cellular and Molecular Medicine. 24(8). 4839–4849. 30 indexed citations
3.
Zhou, Danli, Siqi Zhang, Liang Hu, et al.. (2019). Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain. Journal of Neuroinflammation. 16(1). 83–83. 63 indexed citations
4.
He, Jing, Shidai Jin, Wei Zhang, et al.. (2019). Long non-coding RNA LOC554202 promotes acquired gefitinib resistance in non-small cell lung cancer through upregulating miR-31 expression. Journal of Cancer. 10(24). 6003–6013. 32 indexed citations
5.
Yu, Tao, Pei Ma, Deqin Wu, Yongqian Shu, & Wen Gao. (2018). Functions and mechanisms of microRNA-31 in human cancers. Biomedicine & Pharmacotherapy. 108. 1162–1169. 87 indexed citations
6.
Ni, Wei‐Wei, Wen Huang, Deqin Wu, et al.. (2017). Expression and purification of a major allergen, Pla a 1, from Platanus acerifolia pollen and the preparation of its monoclonal antibody. Molecular Medicine Reports. 16(3). 2887–2892. 7 indexed citations
7.
Cao, Mengda, Miao Guo, Deqin Wu, & Ling Meng. (2017). Pharmacogenomics of Methotrexate: Current Status and Future Outlook. Current Drug Metabolism. 19(14). 1182–1187. 17 indexed citations
8.
Wang, Yongqing, Nana Tang, Ling Meng, et al.. (2012). Safety and Tolerability of Bismuthyl Ecabet Suspension, a Novel Anti-Ulcer Agent, following Single and Multiple Oral Dose Administration in Healthy Chinese Subjects. Clinical Drug Investigation. 32(4). 247–252. 1 indexed citations
9.
Wu, Deqin. (1994). A review of the safety profile of cefixime.. PubMed. 15(6). 1108–19. 12 indexed citations
10.
Wu, Deqin. (1991). Efficacy and Tolerability of Cefixime in Otitis Media. Drugs. 42(Supplement 4). 30–32. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026